Clinical Trials Directory

Trials / Completed

CompletedNCT03447613

Retinal Nerve Fiber Layer Thickness and Cerebrospinal Fluid Aβ/Tau

Association of Retinal Nerve Fiber Layer (RNFL) Thickness With Cerebrospinal Fluid Aβ and Tau Concentration

Status
Completed
Phase
Study type
Observational
Enrollment
86 (actual)
Sponsor
Shanghai 10th People's Hospital · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

To test the hypothesis that retinal nerve fiber layer (RNFL) thickness is correlated with Aβ and Tau concentration of cerebrospinal fluid (CSF) in an older population.

Detailed description

retinal nerve fiber layer (RNFL) thickness changing has been reported in Alzheimer's Disease (AD) patients at an early stage, and has been demonstrated as a potential biomarker able to predict cognitive deterioration (Hinton DR et al., N Engl J Med 1986; London A et al. Nat Rev Neurol 2013; Chang LY et al., Alzheimers Dement 2014). However, whether RNFL thickness is correlated with cerebrospinal fluid (CSF) features of AD pathogenesis (e.g., Aβ and Tau) remains unclear. The investigators thus conducted this observational cohort study to test the correlation between RNFL thickness changing and CSF, to further validate RNFL as a potential AD biomarker.

Conditions

Interventions

TypeNameDescription
PROCEDUREsurgeryAll participants were scheduled to have elective total hip or knee replacement surgery, ureteroscopic lithotripsy and transurethral resection of the prostate under spinal anesthesia at the Shanghai 10th People's Hospital. After 5 years, the investigaors will follow up the participants including cognitive functions, PET-CT, thickness of Retinal Nerve Fiber Layer.

Timeline

Start date
2013-08-01
Primary completion
2014-12-31
Completion
2014-12-31
First posted
2018-02-27
Last updated
2018-11-30

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03447613. Inclusion in this directory is not an endorsement.